Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Immunicum AB (DE:1YG0)

FRANKFURT:1YG0

1YG0

Immunicum AB

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding DE:1YG0?

Track your performance easily

Link Broker

Immunicum AB (1YG0) Income Statement

1 Followers

Immunicum AB Income Statement

Last quarter (Q3 2022), Immunicum AB's total revenue was kr0.00, a decrease of ― from the same quarter last year. In Q3, Immunicum AB's net income was kr-38.60M. See Immunicum AB’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	kr 1.79M	kr 0.00	kr 0.00	kr 0.00	kr 0.00	kr 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expense	kr 125.07M	kr 129.28M	kr 85.96M	kr 44.87M	kr 96.54M	kr 80.70M
Operating Income	kr -123.28M	kr -129.28M	kr -85.96M	kr -44.87M	kr -96.54M	kr -80.70M
Net Non Operating Interest Income Expense	kr -4.22M	kr -3.28M	kr -3.22M	kr -2.92M	kr -14.00K	kr -273.00K
Other Income Expense	-	-	-	-	-	-
Pretax Income	kr -128.35M	kr -133.41M	kr -89.25M	kr -47.77M	kr -97.86M	kr -80.34M
Tax Provision	-	kr 0.00	kr 0.00	kr 0.00	kr 0.00	kr 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	kr -128.35M	kr -133.41M	kr -89.25M	kr -47.77M	kr -97.86M	kr -80.34M
Basic EPS	kr -0.48	kr -0.73	-	-	-	-
Diluted EPS	kr -0.48	kr -0.73	-	-	-	-
Basic Average Shares	kr 595.65M	kr 183.98M	-	-	-	-
Diluted Average Shares	kr 595.65M	kr 183.98M	-	-	-	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	kr 1.10M
Total Expenses	kr 125.07M	kr 129.28M	kr 85.96M	kr 44.87M	kr 96.54M	kr 80.70M
Net Income From Continuing And Discontinued Operation	kr -128.35M	kr -133.41M	kr -89.25M	kr -47.77M	kr -97.86M	kr -80.34M
Normalized Income	kr -128.35M	kr -133.41M	kr -89.25M	kr -47.77M	kr -97.86M	kr -80.97M
Interest Expense	kr 4.45M	kr 3.28M	kr 3.22M	kr 2.92M	kr 14.00K	kr 273.00K
EBIT	kr -123.90M	kr -130.13M	kr -86.03M	kr -44.86M	kr -97.85M	kr -80.06M
EBITDA	kr -122.40M	kr -128.28M	kr -84.25M	kr -44.86M	kr -97.85M	kr -80.06M

Currency in SEK

Immunicum AB Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing